Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Targets for antimigraine therapy: inhibitors of neurogenic plasma protein extravasation

June 18, 1997

Update on SIBIA Neurosciences' SIB-1508Y

June 18, 1997

Neuroprotective effects of ZD-9379 in rat model

June 17, 1997

Specific neuronal nicotinic cholinergic channel modulators from Abbott

June 17, 1997

GABArho receptor antagonists described by University of California

June 17, 1997

Botulinum toxin type A evaluated in cerebral palsy

June 16, 1997

Friedreich's ataxia: possible cause and potential treatments

June 16, 1997

Boston Life Sciences receives notice of patent allowance for CNS growth factor

June 16, 1997

BMS-180048 vs. placebo for acute treatment of migraine

June 16, 1997

Melatonin evaluated in emergency physicians on the night shift

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...